Saphnelo ^*

Saphnelo is a prescription drug used specifically for adults with moderate to severe systemic lupus erythematosus (SLE). It is an add-on therapy, meaning it is taken in combination with other standard lupus medicines. The goal of Saphnelo is to help reduce overall disease activity and manage symptoms that are not fully controlled by other treatments alone. It offers a targeted approach to managing this complex autoimmune condition.

Saphnelo is administered as an intravenous (IV) infusion by a qualified healthcare professional. You will receive it in a hospital or clinic setting. The infusion itself is relatively short, typically taking about 30 minutes to complete. It is not a medication you can take orally or inject at home. This controlled administration ensures you receive the correct dose safely and effectively every time.

Saphnelo is typically given to patients once every four weeks. Your doctor will create a specific treatment schedule for you to follow. Adhering to this regular schedule is very important for maintaining the drug's effectiveness and keeping your lupus symptoms under control. If you expect to miss an appointment, you should contact your doctor’s office right away to reschedule your infusion as soon as possible.

Saphnelo is not a cure for lupus. Currently, there is no cure for systemic lupus erythematosus (SLE). Saphnelo is a treatment designed to manage the disease by reducing its activity and helping to control symptoms. It works by targeting a part of the immune system that is overactive in people with lupus. The goal is to improve your quality of life and reduce lupus flares.

Saphnelo must be kept refrigerated at a specific temperature range until it is time for administration. It is considered a "cold chain" product, meaning its stability depends on proper storage. You will not need to store it at home, as it is prepared and given by your healthcare provider in a clinical setting. They are responsible for ensuring the medication is handled and stored correctly before your infusion.

The most common side effects reported with Saphnelo include upper respiratory tract infections, bronchitis, cough, and infusion-related reactions. Some patients may also develop shingles (herpes zoster). These side effects are generally mild to moderate. However, you should always inform your doctor about any new or persistent symptoms you experience after starting treatment. They can help you manage any potential adverse effects.

Saphnelo is designed to be used in combination with other lupus medications. It is approved as an add-on therapy for patients who are already taking standard treatments like antimalarials, corticosteroids, and other immunosuppressants. You should continue your current treatment plan as directed by your doctor when you start Saphnelo. Never stop or change your other medications without consulting your healthcare provider first.

Saphnelo should not be taken by anyone who has a known allergy to anifrolumab-fnia or any of its ingredients. It is also not recommended for patients who have an active, serious infection. Your doctor will evaluate your health history before prescribing it. This includes checking for past issues like cancer or other conditions affecting the immune system. It is not approved for use in children.

Saphnelo may begin to reduce lupus disease activity within a few weeks, but the full benefits might take longer to become apparent. In clinical trials, some patients saw improvements in their symptoms after a few months of consistent treatment. It is important to continue with your prescribed infusion schedule every four weeks to achieve the best possible outcome. Your doctor will monitor your progress over time.

Saphnelo can increase your risk of developing infections because it affects how your immune system works. Common infections seen in clinical trials include upper respiratory infections and bronchitis. More serious infections can also occur. You should tell your doctor immediately if you develop any signs of an infection, such as fever, chills, persistent cough, or burning pain when you urinate.

Saphnelo may impact your body’s response to vaccines. You should not receive live or live-attenuated vaccines while on this treatment. It is recommended to have all your necessary vaccinations up to date before you start your Saphnelo infusions. Always discuss your vaccination plans with your doctor. They can advise you on which vaccines are safe and appropriate for you during your lupus treatment.

Saphnelo is not a type of chemotherapy. It is a biologic drug known as a monoclonal antibody. Chemotherapy drugs are designed to kill rapidly dividing cells and are most often used for cancer. Saphnelo works differently by specifically targeting the type I interferon receptor to calm parts of the immune system that are overactive in lupus. This targeted action is distinct from the broad effects of chemotherapy.

Saphnelo is not recommended for use during pregnancy or while breastfeeding. There is limited data on its effects on an unborn baby or a nursing infant. If you are pregnant, planning to become pregnant, or breastfeeding, you must discuss this with your doctor. They can explain the potential risks and help you decide on the safest course of treatment for managing your lupus.